Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in BSX — Boston Scientific Corp

CIK 1423053 MIAMI, FL
Back to BSX Full portfolio

Position in BSX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$212,877,084
-$51,759,369 QoQ
Shares Held
4,987,748
+18.3% QoQ
Ownership
0.344%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#52
of 1,474 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Jun 30, 2026
CallValue
$115,304,288
CallShares
2,701,600
PutValue
$105,248,880
PutShares
2,466,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $3,447,350,274 across 95 Medical Devices names. BSX ranks #5 (6.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 8,597,227 $780,112,377
2 MDT
Medtronic plc
 5,373,877 $420,398,397
3 EW
Edwards Lifesciences Corp
 3,997,925 $361,652,295
4 ZBH
Zimmer Biomet Holdings, Inc.
 3,477,472 $299,375,563
5 BSX
Boston Scientific Corp
This page 		4,987,748 $212,877,084
6 GKOS
GLAUKOS Corp
 1,390,017 $194,268,775
7 GEHC
GE HealthCare Technologies Inc.
 2,367,032 $151,513,717
8 PEN
Penumbra Inc
 448,763 $141,696,917

All Filings in BSX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $115,304,288 2,701,600
2026-06-30 $212,877,084 4,987,748
2026-06-30 $105,248,880 2,466,000
2026-03-31 $264,636,453 4,217,314
2026-03-31 $101,146,725 1,611,900
2026-03-31 $57,127,600 910,400
2025-12-31 $57,210,000 600,000
2025-12-31 $455,355,176 4,775,618
2025-12-31 $62,988,210 660,600
2025-09-30 $58,714,682 601,400
2025-09-30 $869,516,698 8,906,245
2025-09-30 $49,137,179 503,300
2025-06-30 $580,476,399 5,404,305
2025-06-30 $50,482,700 470,000
2025-06-30 $84,037,584 782,400
2025-03-31 $548,137,028 5,433,555
2025-03-31 $122,750,784 1,216,800
2025-03-31 $41,643,264 412,800
2024-12-31 $33,503,932 375,100
2024-12-31 $440,477,292 4,931,452
2024-12-31 $57,557,808 644,400
2024-09-30 $24,050,600 287,000
2024-09-30 $820,662,031 9,793,103
2024-09-30 $49,576,080 591,600
2024-06-30 $51,673,710 671,000
2024-06-30 $962,614,757 12,499,867
2024-06-30 $23,780,688 308,800
2024-03-31 $13,403,493 195,700
2024-03-31 $53,340,012 778,800
2024-03-31 $600,935,711 8,774,065
2023-12-31 $38,819,415 671,500
2023-12-31 $519,222,480 8,981,534
2023-12-31 $47,508,258 821,800
2023-09-30 $1,117,048,521 21,156,222
2023-09-30 $36,970,560 700,200
2023-09-30 $50,249,760 951,700
2023-06-30 $22,084,947 408,300
2023-06-30 $836,033,862 15,456,348
2023-06-30 $20,121,480 372,000
2023-03-31 $30,978,576 619,200
2023-03-31 $27,616,560 552,000
2023-03-31 $751,057,714 15,012,147
2022-12-31 $302,342,569 6,534,311
2022-12-31 $7,495,740 162,000
2022-12-31 $25,758,509 556,700
2022-09-30 $18,226,338 470,600
2022-09-30 $561,255,871 14,491,502
2022-09-30 $17,513,706 452,200
2022-06-30 $467,034,431 12,531,109
2022-06-30 $21,154,452 567,600

Report a Problem

Category
Description
Email (optional, for follow-up)